EFPIA Italy: All Big Pharma Value Transfers

EFPIA Italy: All Big Pharma Value Transfers

With this article we want to make available to everyone our collection of EFPIA reports of the main pharmaceutical industries from 2015 to 2018.

The Disclosure Code (EFPIA - Disclosure Code) requires all companies associated with EFPIA (the European Federation of Pharmaceutical Industries and Associations) or national associations which are themselves members of EFPIA to publish relationships with doctors (HCP - Healthcare Professionals) and their organizations (HCO - Healthcare Oganisations).

The Code is applied in the 33 European countries participating in EFPIA and also in the countries that decide to adopt it voluntarily. The geographical area covered ranges from Portugal to Russia, from Turkey to Iceland and from Greece to Scandinavia but only the USA and France provide for the transparency code by law.


What is published in the EFPIA reports?

Each company must indicate the name of the doctors and organizations with which it has maintained valuable relationships with respect to the following topics:

  • research and development of new drugs through clinical studies carried out in hospitals, universities and public and private health facilities;
  • scientific advice;
  • scientific seminars and conferences, offering information and updating;
  • support for conferences and ECM (Continuing Medical Education) courses organized by public structures, universities, scientific societies and ECM accredited providers.

The Value Transfers from 2016 to 2018 exceed 580 million euros

total efpia 1


The increase in transfers of value

total efpia 2


The first pharmaceutical industries in order of Value Transfers

total efpia 3


EFPIA reports (in alphabetical order)

AbbVie

Alcon

Angelini

Bayer

Dompé

Celgene

Gilead Sciences

GlaxoSmithKline

Lilly

Menarini

Merck

MSD

Novartis Farma

Pfizer

Pfizer Italy

Roche

Sandoz

Sanofi

Pan